Oral Answers to Questions

Andrew Gwynne Excerpts

Tuesday 18th January 2022 Commons Chamber

[Sajid Javid]

I absolutely agree with my hon. Friend about a unified approach to shared challenges such as covid-19, and that unified approach being the best way forward. Across the UK, we have built the largest diagnostic network in British history and our testing programme has been one of the most important lines of defence, alongside our UK-wide vaccination programme. Our procurement of tests, antivirals and vaccines has been another fantastic example of the strength of the Union.

[Andrew Gwynne (Denton and Reddish) (Lab)]

“Always try and buy British first” was what the Secretary of State said a few moments ago, but a few weeks ago it was reported that plans to manufacture lateral flow tests here in the UK were shelved because the Government were scared that they might be accused of handing out dodgy deals to their mates. I know the Minister has form on this, but on this point they were misguided. Can he now say to the House that that was not the case and that he was not running scared of a transparent procurement policy, and that he will now do all he can to turbocharge British manufacturing and get British lateral flow tests in the system, so that we do not ever suffer again from those avoidable shortages we saw over Christmas?

[Sajid Javid]

First, I think the hon. Gentleman accused me of doing something inappropriate, and I think that that is not appropriate, unless he has something else to say or some evidence, but it is true to form for the Labour Front Bench, which just constantly makes things up to make false points. When it comes to testing, as he has just heard me say, we have purchased 1.7 billion lateral flow tests since the start of the pandemic. Wherever possible, whether it is PCR testing or lateral flow testing, whenever tests are approved by our independent regulator, we buy British.